This Biotech with Breakout MS Drug Draws Big Investment
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Index funds vary in tax efficiency; choosing the right ones can lower taxable gains and boost after-tax returns. This guide covers tax-smart picks and strategies.
24,188 articlesA breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
Nebius has drawn attention with bold AI capacity announcements and aggressive revenue targets. This guide breaks down...
Bitcoin climbs on rising demand from whales and regulated ETFs, suggesting more upside may be ahead. Here are the key...
As planet labs (pl) 2026 nears, investors weigh growth against costs in a fast-evolving space data market. This guide...
Iranian tensions send energy prices higher as LNG and crude flows shift. A handful of U.S. energy stocks have surged ...
A federal probe into Tesla's FSD system raises questions for investors about safety, costs, and stock risk. This guid...
Retail investors surged into crypto trading as access expanded, but the market remains tilted toward institutions and...
Mosaic's Q3 2025 results spotlight a sharply growing Brazil business, with Brazil EBITDA up 190% year over year. Yet ...
SWIFT is moving its blockchain-based cross-border settlement from pilot to production-scale, with a mid-2026 MVP and ...
A single 2019 decision helped Oracle pivot from legacy database vendor to an AI-ready cloud player. This article brea...
Meta Platforms is pursuing a bold path toward a $9 trillion market cap by 2031. This article breaks down the feasibil...
When an insider doubles down on a falling stock, investors sit up and take notice. This article breaks down what it c...